DekaBank Deutsche Girozentrale’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-292,400
| Closed | -$13.5M | – | 1184 |
|
|
2019
Q2 | $13.5M | Buy |
292,400
+180,800
| +162% | +$5.08M | 0.07% | 277 |
|
|
2019
Q1 | $1.73M | Sell |
111,600
-44,600
| -29% | -$929K | 0.01% | 639 |
|
|
2018
Q4 | $2.26M | Buy |
156,200
+44,600
| +40% | +$677K | 0.01% | 517 |
|
|
2018
Q3 | $1.73M | Sell |
111,600
-2,900
| -3% | -$44.4K | 0.01% | 652 |
|
|
2018
Q2 | $1.94M | Sell |
114,500
-75,500
| -40% | -$1.2M | 0.01% | 595 |
|
|
2018
Q1 | $3.09M | Buy |
190,000
+95,400
| +101% | +$1.53M | 0.02% | 483 |
|
|
2017
Q4 | $850K | Hold |
94,600
| – | – | 0.01% | 725 |
|
|
2017
Q3 | $850K | Hold |
94,600
| – | – | 0.01% | 733 |
|
|
2017
Q2 | $799K | Hold |
94,600
| – | – | 0.01% | 742 |
|
|
2017
Q1 | $859K | Buy |
94,600
+24,600
| +35% | +$262K | 0.01% | 633 |
|
|
2016
Q4 | $606K | Buy |
+70,000
| New | +$515K | 0.01% | 631 |
|
|
2016
Q2 | – | Sell |
-68,000
| Closed | -$198K | – | 1080 |
|
|
2016
Q1 | $198K | Sell |
68,000
-4,400
| -6% | -$13.2K | ﹤0.01% | 850 |
|
|
2015
Q4 | $300K | Buy |
72,400
+1,500
| +2% | +$6.85K | ﹤0.01% | 798 |
|
|
2015
Q3 | $323K | Buy |
70,900
+3,000
| +4% | +$17.8K | ﹤0.01% | 776 |
|
|
2015
Q2 | $490K | Buy |
67,900
+2,500
| +4% | +$18.4K | 0.01% | 706 |
|
|
2015
Q1 | $482K | Sell |
65,400
-5,500
| -8% | -$39.2K | 0.01% | 726 |
|
|
2014
Q4 | $338K | Sell |
70,900
-6,500
| -8% | -$25.7K | ﹤0.01% | 773 |
|
|
2014
Q3 | $276K | Buy |
77,400
+5,000
| +7% | +$19.7K | ﹤0.01% | 767 |
|
|
2014
Q2 | $330K | Sell |
72,400
-4,000
| -5% | -$16.5K | 0.01% | 686 |
|
|
2014
Q1 | $359K | Buy |
76,400
+9,500
| +14% | +$47.8K | 0.01% | 634 |
|
|
2013
Q4 | $326K | Buy |
66,900
+1,500
| +2% | +$8.17K | 0.01% | 603 |
|
|
2013
Q3 | $407K | Buy |
+65,400
| New | +$388K | 0.01% | 576 |
|
Other funds holding ARRY
DekaBank Deutsche Girozentrale's ARRY Position: Q3 2019 in Review
DekaBank Deutsche Girozentrale sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 292,400 shares — an estimated $13.5M sold.
DekaBank Deutsche Girozentrale first reported a position in ARRY in Q3 2013 and held it in 22 quarters. The position peaked at $13.5M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- DekaBank Deutsche Girozentrale reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- DekaBank Deutsche Girozentrale sold 292,400 Array Biopharma Inc shares in Q3 2019, an estimated $13.5M.
- DekaBank Deutsche Girozentrale first reported a position in Array Biopharma Inc in Q3 2013 and held it in 22 quarters.
- DekaBank Deutsche Girozentrale's Array Biopharma Inc position peaked at $13.5M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2019, filed 14 Nov 2019.